Filing Details

Accession Number:
0001179110-20-005089
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-24 16:13:41
Reporting Period:
2020-04-22
Accepted Time:
2020-04-24 16:13:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1709401 Rubius Therapeutics Inc. RUBY Biological Products, (No Disgnostic Substances) (2836) 042688109
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799032 M. Christina Coughlin C/O Rubius Therapeutics, Inc.
399 Binney Street, Suite 300
Cambridge MA 02139
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-22 19,000 $5.52 19,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct